Clinical Trial Update: Study of Azithromycin for Lymphocytic Bronchiolitis/Bronchitis After Lung Transplantation [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating azithromycin for lymphocytic bronchiolitis/bronchitis after lung transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphocytic Bronchiolitis

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: KU Leuven | Conditions: Lymphocytic Bronchi(Oli)Tis Post-lung Transplantation | Phase 4 | Status: COMPLETED